Comparative study of photodynamic therapy with 5%,10% and 20% aminolevulinic acid in treatment of facial verruca planae, a randomized clinical trial

Comparative study of photodynamic therapy with 5%, 10% and 20% aminolevulinic acid in treatment of facial verruca planae, a randomized clinical trial

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-11001756

Enrollment

Unknown

Registered

2011-12-01

Start date

2011-07-28

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

verruca planae

Interventions

3 groups:photodynamic therapy

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. recalcitrant (in our study defined as treatment in vain by any method for more than 3 months) bilaterally facial verrcua planae; 2. Patients in the study were at least 18 years of age.

Exclusion criteria

Exclusion criteria: Immosuppression, general poor health with expected poor compliance, pregnancy, breast-feeding, or other treatments within the previous 6 months.

Design outcomes

Primary

Measure	Time frame
lesions clearance rate;	—

Countries

China

Contacts

Public ContactQiang Li

qiangli@fmmu.edu.cn+86 29 84775406-8307

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026